发明名称 |
Antimikrobielle forbindelser og formuleringer |
摘要 |
<p>The invention relates to a peptide consisting of 2-4 amino acids comprising at least three lipophilic groups of at least 5 non-hydrogen atoms wherein one of the molecule's lipophilic groups incorporates 6 or more non-hydrogen atoms and a second lipophilic group incorporates 10 or more non-hydrogen atoms and wherein at least one lipophilic group incorporates a closed ring of at least 6 non-hydrogen atoms, said peptide having at least one more cationic than anionic moiety, and wherein at least one of the amino acids has a cationic side chain (R group) and at least one of the lipophilic groups is an amino acid side chain (R group), for use as an antitumoural agent and to a peptide consisting of 2-4 amino acids comprising a lipophilic group comprising at least 13 non-hydrogen atoms and one or more closed rings of 4 or more non-hydrogen atoms, wherein at least one of the amino acids has a cationic side chain (R group) and at least one of the amino acid side chains (R groups) is a lipophilic group of at least 4 non-hydrogen atoms, said peptide having at least two more cationic than anionic moieties, also for use as an antitumoural agent.</p> |
申请公布号 |
DK1263471(T3) |
申请公布日期 |
2012.02.06 |
申请号 |
DK20010910034T |
申请日期 |
2001.03.09 |
申请人 |
LYTIX BIOPHARMA AS |
发明人 |
MARKO, ISTVAN;SVENDSEN, JOHN, SIGURD;STENSEN, WENCHE;HAUG, BENGT, ERIK;REKDAL, OYSTEIN;SKAR, MERETE, LINCHAUSEN;STROEM, MORTEN, BOEHMER |
分类号 |
A61K45/00;A61K47/48;A61K38/00;A61K38/08;A61P31/04;C07K5/06;C07K5/068;C07K5/072;C07K5/078;C07K5/09;C07K5/097;C07K5/11;C07K5/117;C07K7/06 |
主分类号 |
A61K45/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|